血液透析机构抗菌药物管理项目的临床与经济获益:决策分析模型
该研究建立决策分析模型,评估在美国门诊透析机构实施全国性抗菌药物管理项目(假设不必要抗菌药物剂量减少20%)的临床与经济后果。模型预测每年可减少2182例耐药菌和艰难梭菌感染(4.8%)、629例感染相关死亡(4.6%),并节省成本106,893,517美元(5.0%)。
要点
- 门诊血透机构约30%的抗菌药物剂量被认为不必要。
- 实施管理项目(不必要剂量减20%)预计每年减少2182例感染和629例死亡。
核心结论
- 在门诊透析机构实施抗菌药物管理项目可大幅减少耐药菌和艰难梭菌感染、感染相关死亡及成本。
研究设计与样本
- 决策分析模型,评估在美国门诊透析机构实施全国性抗菌药物管理项目的临床与经济后果,分析对象为美国所有门诊血液透析患者。
主要发现
- 全国范围实施预计每年减少2182例耐药菌和艰难梭菌感染(4.8%减少)。
- 预计每年减少629例感染相关死亡(4.6%减少)。
- 预计每年节省成本106,893,517美元(5.0%减少)。
- 模型对临床参数最敏感,而非抗菌药物成本。
关键数值与推荐
- 假设不必要抗菌药物剂量减少20%计算项目价值。
- 事件概率、抗菌药物方案和医疗成本来源于公开数据。
临床怎么用
- 支持在门诊血液透析机构推行抗菌药物管理项目以改善处方实践。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Infections caused by multidrug-resistant organisms and Clostridium difficile are associated with substantial morbidity and mortality as well as excess costs. Antimicrobial exposure is the leading cause for these infections. Approximately 30% of antimicrobial doses administered in outpatient hemodialysis facilities are considered unnecessary. Implementing an antimicrobial stewardship program in outpatient hemodialysis facilities aimed at improving prescribing practices would have important clinical and economic benefits. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We developed a decision analytic model of antimicrobial use on the clinical and economic consequences of implementing a nationwide antimicrobial stewardship program in outpatient dialysis facilities. The main outcomes were total antimicrobial use, infections caused by multidrug-resistant organisms and C. difficile, infection-related mortality, and total costs. The analysis considered all patients on outpatient hemodialysis in the United States. The value of implementing antimicrobial stewardship programs, assuming a 20% decrease in unnecessary antimicrobial doses, was calculated as the incremental differences in clinical end points and cost outcomes. Event probabilities, antimicrobial regimens, and health care costs were informed by publicly available sources. RESULTS: On a national level, implementation of antimicrobial stewardship programs was predicted to result in 2182 fewer infections caused by multidrug-resistant organisms and C. difficile (4.8% reduction), 629 fewer infection-related deaths (4.6% reduction), and a cost savings of $106,893,517 (5.0% reduction) per year. The model was most sensitive to clinical parameters as opposed to antimicrobial costs. CONCLUSIONS: The model suggests that implementation of antimicrobial stewardship programs in outpatient dialysis facilities would result in substantial reductions in infections caused by multidrug-resistant organisms and C. difficile, infection-related deaths, and costs.
引用
- D'Agata EMC, Tran D, Bautista J, et al. Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities: A Decision Analytic Model. Clin J Am Soc Nephrol. 2018. PMID: 30139804. doi:10.2215/CJN.12521117
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。